Cargando…

Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis

BACKGROUND: Cystic fibrosis (CF) lung disease is defined by large numbers of neutrophils and associated damaging products in the airway. Delayed neutrophil apoptosis is described in CF although it is unclear whether this is a primary neutrophil defect or a response to chronic inflammation. Increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Robert D, Hardisty, Gareth, Regan, Kate H, Smith, Maeve, Robb, Calum T, Duffin, Rodger, Mackellar, Annie, Felton, Jennifer M, Paemka, Lily, McCullagh, Brian N, Lucas, Christopher D, Dorward, David A, McKone, Edward F, Cooke, Gordon, Donnelly, Seamas C, Singh, Pradeep K, Stoltz, David A, Haslett, Christopher, McCray, Paul B, Whyte, Moira K B, Rossi, Adriano G, Davidson, Donald J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771859/
https://www.ncbi.nlm.nih.gov/pubmed/28916704
http://dx.doi.org/10.1136/thoraxjnl-2017-210134
_version_ 1783293314931359744
author Gray, Robert D
Hardisty, Gareth
Regan, Kate H
Smith, Maeve
Robb, Calum T
Duffin, Rodger
Mackellar, Annie
Felton, Jennifer M
Paemka, Lily
McCullagh, Brian N
Lucas, Christopher D
Dorward, David A
McKone, Edward F
Cooke, Gordon
Donnelly, Seamas C
Singh, Pradeep K
Stoltz, David A
Haslett, Christopher
McCray, Paul B
Whyte, Moira K B
Rossi, Adriano G
Davidson, Donald J
author_facet Gray, Robert D
Hardisty, Gareth
Regan, Kate H
Smith, Maeve
Robb, Calum T
Duffin, Rodger
Mackellar, Annie
Felton, Jennifer M
Paemka, Lily
McCullagh, Brian N
Lucas, Christopher D
Dorward, David A
McKone, Edward F
Cooke, Gordon
Donnelly, Seamas C
Singh, Pradeep K
Stoltz, David A
Haslett, Christopher
McCray, Paul B
Whyte, Moira K B
Rossi, Adriano G
Davidson, Donald J
author_sort Gray, Robert D
collection PubMed
description BACKGROUND: Cystic fibrosis (CF) lung disease is defined by large numbers of neutrophils and associated damaging products in the airway. Delayed neutrophil apoptosis is described in CF although it is unclear whether this is a primary neutrophil defect or a response to chronic inflammation. Increased levels of neutrophil extracellular traps (NETs) have been measured in CF and we aimed to investigate the causal relationship between these phenomena and their potential to serve as a driver of inflammation. We hypothesised that the delay in apoptosis in CF is a primary defect and preferentially allows CF neutrophils to form NETs, contributing to inflammation. METHODS: Blood neutrophils were isolated from patients with CF, CF pigs and appropriate controls. Neutrophils were also obtained from patients with CF before and after commencing ivacaftor. Apoptosis was assessed by morphology and flow cytometry. NET formation was determined by fluorescent microscopy and DNA release assays. NET interaction with macrophages was examined by measuring cytokine generation with ELISA and qRT-PCR. RESULTS: CF neutrophils live longer due to decreased apoptosis. This was observed in both cystic fibrosis transmembrane conductance regulator (CFTR) null piglets and patients with CF, and furthermore was reversed by ivacaftor (CFTR potentiator) in patients with gating (G551D) mutations. CF neutrophils formed more NETs and this was reversed by cyclin-dependent kinase inhibitor exposure. NETs provided a proinflammatory stimulus to macrophages, which was enhanced in CF. CONCLUSIONS: CF neutrophils have a prosurvival phenotype that is associated with an absence of CFTR function and allows increased NET production, which can in turn induce inflammation. Augmenting neutrophil apoptosis in CF may allow more appropriate neutrophil disposal, decreasing NET formation and thus inflammation.
format Online
Article
Text
id pubmed-5771859
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57718592018-02-09 Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis Gray, Robert D Hardisty, Gareth Regan, Kate H Smith, Maeve Robb, Calum T Duffin, Rodger Mackellar, Annie Felton, Jennifer M Paemka, Lily McCullagh, Brian N Lucas, Christopher D Dorward, David A McKone, Edward F Cooke, Gordon Donnelly, Seamas C Singh, Pradeep K Stoltz, David A Haslett, Christopher McCray, Paul B Whyte, Moira K B Rossi, Adriano G Davidson, Donald J Thorax Cystic Fibrosis BACKGROUND: Cystic fibrosis (CF) lung disease is defined by large numbers of neutrophils and associated damaging products in the airway. Delayed neutrophil apoptosis is described in CF although it is unclear whether this is a primary neutrophil defect or a response to chronic inflammation. Increased levels of neutrophil extracellular traps (NETs) have been measured in CF and we aimed to investigate the causal relationship between these phenomena and their potential to serve as a driver of inflammation. We hypothesised that the delay in apoptosis in CF is a primary defect and preferentially allows CF neutrophils to form NETs, contributing to inflammation. METHODS: Blood neutrophils were isolated from patients with CF, CF pigs and appropriate controls. Neutrophils were also obtained from patients with CF before and after commencing ivacaftor. Apoptosis was assessed by morphology and flow cytometry. NET formation was determined by fluorescent microscopy and DNA release assays. NET interaction with macrophages was examined by measuring cytokine generation with ELISA and qRT-PCR. RESULTS: CF neutrophils live longer due to decreased apoptosis. This was observed in both cystic fibrosis transmembrane conductance regulator (CFTR) null piglets and patients with CF, and furthermore was reversed by ivacaftor (CFTR potentiator) in patients with gating (G551D) mutations. CF neutrophils formed more NETs and this was reversed by cyclin-dependent kinase inhibitor exposure. NETs provided a proinflammatory stimulus to macrophages, which was enhanced in CF. CONCLUSIONS: CF neutrophils have a prosurvival phenotype that is associated with an absence of CFTR function and allows increased NET production, which can in turn induce inflammation. Augmenting neutrophil apoptosis in CF may allow more appropriate neutrophil disposal, decreasing NET formation and thus inflammation. BMJ Publishing Group 2018-02 2017-09-15 /pmc/articles/PMC5771859/ /pubmed/28916704 http://dx.doi.org/10.1136/thoraxjnl-2017-210134 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Cystic Fibrosis
Gray, Robert D
Hardisty, Gareth
Regan, Kate H
Smith, Maeve
Robb, Calum T
Duffin, Rodger
Mackellar, Annie
Felton, Jennifer M
Paemka, Lily
McCullagh, Brian N
Lucas, Christopher D
Dorward, David A
McKone, Edward F
Cooke, Gordon
Donnelly, Seamas C
Singh, Pradeep K
Stoltz, David A
Haslett, Christopher
McCray, Paul B
Whyte, Moira K B
Rossi, Adriano G
Davidson, Donald J
Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
title Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
title_full Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
title_fullStr Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
title_full_unstemmed Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
title_short Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
title_sort delayed neutrophil apoptosis enhances net formation in cystic fibrosis
topic Cystic Fibrosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771859/
https://www.ncbi.nlm.nih.gov/pubmed/28916704
http://dx.doi.org/10.1136/thoraxjnl-2017-210134
work_keys_str_mv AT grayrobertd delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT hardistygareth delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT regankateh delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT smithmaeve delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT robbcalumt delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT duffinrodger delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT mackellarannie delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT feltonjenniferm delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT paemkalily delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT mccullaghbriann delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT lucaschristopherd delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT dorwarddavida delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT mckoneedwardf delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT cookegordon delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT donnellyseamasc delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT singhpradeepk delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT stoltzdavida delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT haslettchristopher delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT mccraypaulb delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT whytemoirakb delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT rossiadrianog delayedneutrophilapoptosisenhancesnetformationincysticfibrosis
AT davidsondonaldj delayedneutrophilapoptosisenhancesnetformationincysticfibrosis